Anxiety in Alzheimer's disease rats is independent of memory and impacted by genotype, age, sex, and exercise

被引:3
|
作者
Lopez, Danielle C. [1 ]
White, Zachary J. [1 ]
Hall, Stephanie E. [1 ,2 ]
机构
[1] Kansas State Coll Vet Med, Anat & Physiol Dept, Manhattan, KS USA
[2] Kansas State Coll Vet Med, Anat & Physiol Dept, 1620 Denison Ave, Manhattan, KS 66506 USA
基金
美国国家卫生研究院;
关键词
Alzheimer's disease; anxiety; exercise; memory; TgF344-AD; ELEVATED PLUS-MAZE; RODENT MODELS; BEHAVIOR;
D O I
10.1002/alz.13813
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
INTRODUCTION: Alzheimer's disease (AD) is characterized by cognitive impairments; however, heightened anxiety often accompanies and, in some cases, exacerbates cognitive its. The present study aims to understand the influence of multiple variables on anxiety-like behavior in TgF344-AD rats and determine whether anxiety impacts memory performance. METHODS: An elevated plus maze was used to assess anxiety-like behavior in the established colony (n = 107). Influences of age, sex, genotype, and exercise on anxiety were evaluated via multiple linear regression. Correlation analysis evaluated the relationship between anxiety and memory performance. RESULTS: Age (P < 0.05) and AD genotype (P < 0.001) were associated with increasing anxiety, while exercise (P < 0.05) was associated with decreasing anxiety. Female AD animals displayed more anxiety-like behavior versus wild-type female (P < 0.001) and AD male (P < 0.05) littermates. DISCUSSION: Concluding that while factors such as age, sex, AD genotype, and training status can impact anxiety levels in the TgF344-AD model, anxiety level did not impact memory performance. Highlights Increased anxiety-like behavior in TgF344-AD rats does not correlate with declines in memory performance. Predictors of higher anxiety-like behaviors in the TgF344-AD rat include age, Alzheimer's disease (AD) genotype, and sex with female AD animals experiencing greater anxiety compared to female wild-type or male AD. Exercise training leads to decreased anxiety-like behaviors in the TgF344-AD rat.
引用
收藏
页码:3543 / 3550
页数:8
相关论文
共 50 条
  • [1] A review on the new age methodologies for early detection of Alzheimer&apos;s and Parkinson&apos;s disease
    Ghosh, Nabanita
    Sinha, Krishnendu
    Sil, Parames C.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2024, 134 (05) : 602 - 613
  • [2] Sex differences in risk factors, burden, and outcomes of cerebrovascular disease in Alzheimer&apos;s disease populations
    Morrison, Cassandra
    Dadar, Mahsa
    Collins, Donald Louis
    ALZHEIMERS & DEMENTIA, 2024, 20 (01) : 34 - 46
  • [3] New directions for Alzheimer&apos;s disease research from the Jackson Laboratory Center for Alzheimer&apos;s and Dementia Research 2022 workshop
    Telpoukhovskaia, Maria A.
    Murdy, Thomas J.
    Marola, Olivia J.
    Charland, Kevin
    Maclean, Michael
    Luquez, Tain
    Lish, Alexandra M.
    Neuner, Sarah
    Dunn, Amy
    Onos, Kristen D.
    Wiley, Jesse
    Archer, Derek
    Huentelman, Matthew J.
    Arnold, Matthias
    Menon, Vilas
    Goate, Alison
    Van Eldik, Linda J.
    Territo, Paul R.
    Howell, Gareth R.
    Carter, Gregory W.
    O'Connell, Kristen M. S.
    Kaczorowski, Catherine C.
    ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS, 2024, 10 (01)
  • [4] Subcellular proteomics insights into Alzheimer&apos;s disease development
    Liang, Zhiyuan
    Zhuang, Hongbin
    Cao, Xueshan
    Ma, Guanwei
    Shen, Liming
    PROTEOMICS CLINICAL APPLICATIONS, 2023,
  • [5] The role of membrane trafficking and retromer complex in Parkinson&apos;s and Alzheimer&apos;s disease
    Abdul-Rahman, Toufik
    Ghosh, Shankhaneel
    Kalmanovich, Jacob B.
    Awuah, Andrew Wireko
    Zivcevska, Marija
    Khalifa, Samar
    Bassey, Esther Edet
    Ali, Namarig Alnil
    Ferreira, Matheus Mendes dos Santos
    Umar, Tungki Pratama
    Garg, Neil
    Nweze, Victor Nnanna
    Inturu, Venkata Sai Sulekhya
    Abdelwahab, Maya Magdy
    Kurian, Sneha
    Alexiou, Athanasios
    Alfaleh, Mohammed
    Alqurashi, Thamer M. A.
    Ashraf, Ghulam Md
    JOURNAL OF NEUROSCIENCE RESEARCH, 2024, 102 (01)
  • [6] Unraveling Amentoflavone&apos;s Therapeutic Potential in Alzheimer&apos;s Disease: A Preclinical Assessment
    Singh, Sushma
    Agrawal, Neetu
    Goyal, Ahsas
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2024, 27 (13) : 1851 - 1860
  • [7] Awareness and cognitive rehabilitation in Alzheimer&apos;s disease and frontotemporal dementia
    Salmon, Eric
    Lekeu, Francoise
    Quittre, Anne
    Godichard, Vinciane
    Olivier, Catherine
    Wojtasik, Vinciane
    Bastin, Christine
    ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS, 2024, 10 (02)
  • [8] Insights and recommendations for working collaboratively and improving care in Alzheimer&apos;s disease: Learnings from the Finding Alzheimer&apos;s Solutions Together (FAST) Council
    Roeser, Jannice
    Bayliss, Nikki
    Blom, Marco
    Croney, Ruth
    Lanman, Lydia
    Laks, Jerson
    Lyons, Marco
    Proulx, Lea
    Tsatali, Marianna
    Westerlund, Karin
    Georges, Jean
    HEALTH EXPECTATIONS, 2024, 27 (02)
  • [9] Exploring the significance of lipids in Alzheimer&apos;s disease and the potential of extracellular vesicles
    Su, Huaqi
    Masters, Colin L.
    Bush, Ashley I.
    Barnham, Kevin J.
    Reid, Gavin E.
    Vella, Laura J.
    PROTEOMICS, 2023,
  • [10] Memantine&apos;s double duty? Investigating its impact on epilepsy control in Alzheimer&apos;s disease
    Rayala, Harika
    Kapur, Jaideep
    El-Haija, Hiba Abu
    Parikh, Prachi
    Zawar, Ifrah
    EPILEPTIC DISORDERS, 2024, 26 (02) : 261 - 263